Table 1 Associations between FBP1 and -3 and clinical parameters in prostate cancer (low, high expression: for definition see text).
FPB1 | FBP3 | |||||||
|---|---|---|---|---|---|---|---|---|
n | low n (%) | high n(%) | p-value | n | low n (%) | high n(%) | p-value | |
pT2 | 42 | 29 (69.0) | 13 (31.0) | n.s. | 44 | 31 (70.5) | 13 (29.5) | n.s. |
pT3/4 | 49 | 33 (67.3) | 16 (32.7) | 51 | 35 (68.6) | 16 (31.4) | ||
Gleason score 2–6 | 23 | 16 (69.6) | 7 (30.4) | n.s. | 24 | 14 (58.3) | 10 (41.7) | n.s. |
Gleason score 7–10 | 67 | 46 (68.7) | 21 (31.3) | 70 | 51 (72.9) | 19 (27.1) | ||
PSA relapse | 48 | 34 (70.8) | 14 (29.2) | n.s. | 49 | 32 (65.3) | 17 (34.7) | n.s. |
No PSA relapse | 43 | 28 (65.1) | 15 (34.9) | 46 | 34 (73.9) | 12 (26.1) | ||
FBP1 low | 62 | 62 | 48 (77.4) | 14 (22.6) | 0.017 | |||
FBP1 high | 29 | 29 | 15 (51.7) | 14 (48.3) | ||||
FBP3 low | 63 | 48 (76.2) | 15 (23.8) | 0.017 | 66 | |||
FBP3 high | 28 | 14 (50.0) | 14 (50.0) | 29 | ||||